GLP-1 receptor agonists work by mimicking the action of endogenous GLP-1, a hormone that stimulates insulin secretion in a glucose-dependent manner, suppresses glucagon release, slows gastric emptying, and promotes satiety through central nervous system pathways
In patients using Ozempic, symptoms of nAMD were rapid-onset, occurring after the start of treatment, and were sometimes misdiagnosed as typical diabetic vision changes
Additionally, those with type 1 diabetes who use SGLT2 inhibitors run the risk of developing diabetic ketoacidosis (DKA)
All prescriptions are up to a medical providers discretion
It seems to help dramatically with my stubborn areas
faqs GLP-1 microdosing is the use of very low, personalized doses of GLP-1 receptor agonists to support appetite control, blood sugar balance, and fat loss while minimizing side effects commonly seen with standard dosing